Chagas' Disease: Lymphoma Growth in Rabbits Treated with Benznidazole

Antônio R. L. TeixeiraUniversity of Brasília, Brasília, Brazil

Search for other papers by Antônio R. L. Teixeira in
Current site
Google Scholar
PubMed
Close
,
José Carlos CórdobaUniversity of Brasília, Brasília, Brazil

Search for other papers by José Carlos Córdoba in
Current site
Google Scholar
PubMed
Close
,
Inês Souto MaiorUniversity of Brasília, Brasília, Brazil

Search for other papers by Inês Souto Maior in
Current site
Google Scholar
PubMed
Close
, and
Edwin SolórzanoUniversity of Brasília, Brasília, Brazil

Search for other papers by Edwin Solórzano in
Current site
Google Scholar
PubMed
Close
Restricted access

Administration of the trypanocidal drug, Benznidazole (N-benzyl-2-nitroimidazoleacetamide) to Trypanosoma cruzi-infected rabbits did not arrest the destructive Chagas' heart myocarditis. A typical feature of lymphocytic infiltrates associated with non-parasitized heart cell lysis was present in both treated and untreated groups of rabbits. Benznidazole-treated rabbits had their survival time shortened, probably as a consequence of Chagas' heart disease and of the development of lymphomas. The survival time of untreated T. cruzi-infected rabbits was 765 ± 639 days and those treated with Benznidazole in the chronic phase of infection survived for 392 ± 571 days. Malignant, non-Hodgkin's lymphomas were present in 38% of the rabbits that received the nitroarene therapy. Testicular atrophy was observed in 2 out of 10 nitroarene-treated rabbits. Benznidazole administration caused severe cell-mediated immunosuppression in T. cruzi-infected and BCG-immunized rabbits. Specific antibodies against the parasite and an unrelated antigen were detected in high levels, regardless of the nitroarene administration.

Save